<p>Shilanski &amp; Associates Inc. 在最近向证券交易委员会提交的文件中表示，在第三季度将其在 Axon Enterprise, Inc (NASDAQ:AXON - 免费报告) 的持股减少了 39.9%。该基金在季度内出售了 2,737 股后，持有生物技术公司 4,121 股股票。Shilanski &amp; Associates Inc. 在 Axon Enterprise 的持股在最近一个季度末价值为 2,957,000 美元。</p>
<p>获取 <strong>Axon Enterprise</strong> 的提醒：</p>
<ul>
<li>为什么 Axon 的 16% 激增预示着公共安全技术的新纪元</li>
</ul>
<p>其他几家对冲基金也调整了对该股票的持股。Westside Investment Management Inc. 在第二季度将其在 Axon Enterprise 的持股增加了 4.8%。Westside Investment Management Inc. 目前持有 283 股生物技术公司的股票，价值 225,000 美元，此前在上个季度购买了额外的 13 股。CVA Family Office LLC 在第二季度将其在 Axon Enterprise 的持股增加了 26.9%。CVA Family Office LLC 目前持有 66 股生物技术公司的股票，价值 55,000 美元，此前在上个季度购买了额外的 14 股。Newbridge Financial Services Group Inc. 在第二季度将其在 Axon Enterprise 的持股增加了 2.8%。Newbridge Financial Services Group Inc. 目前持有 508 股生物技术公司的股票，价值 421,000 美元，此前在该期间购买了额外的 14 股。Evergreen Capital Management LLC 在第二季度将其在 Axon Enterprise 的持股增加了 3.8%。Evergreen Capital Management LLC 目前持有 413 股生物技术公司的股票，价值 342,000 美元，此前在上个季度购买了额外的 15 股。最后，STF Management LP 在第二季度将其在 Axon Enterprise 的持股增加了 1.4%。STF Management LP 目前持有 1,164 股生物技术公司的股票，价值 964,000 美元，此前在上个季度购买了额外的 16 股。79.08% 的股票由对冲基金和其他机构投资者持有。</p>
<h2>华尔街分析师预测增长</h2>
<p>多家研究公司最近对 AXON 发表了评论。Piper Sandler 在 11 月 5 日的研究报告中将 Axon Enterprise 的目标价格从 893.00 美元下调至 753.00 美元，并对该公司给予了 “增持” 评级。Needham &amp; Company LLC 在 9 月 24 日的研究报告中重申了对 Axon Enterprise 的 “买入” 评级，并给出了 870.00 美元的目标价格。高盛集团在 11 月 5 日的报告中将 Axon Enterprise 的目标价格从 940.00 美元下调至 800.00 美元，并对该股票给予了 “买入” 评级。加拿大皇家银行在 11 月 17 日的研究报告中开始覆盖 Axon Enterprise，并给予了 “跑赢大盘” 评级和 860.00 美元的目标价格。最后，Cowen 在 11 月 5 日的研究报告中重申了对 Axon Enterprise 的 “买入” 评级。十四位研究分析师对该股票给予了买入评级，四位给予了持有评级。根据 MarketBeat 的数据，该股票的平均评级为 “适度买入”，平均目标价格为 802.71 美元。</p>
<ul>
<li>MarketBeat 周回顾 – 06/02 - 06/06</li>
</ul>
<p><strong>阅读我们关于 AXON 的最新研究报告</strong></p>
<h2>Axon Enterprise 的内部交易</h2>
<p>在相关消息中，首席执行官 Patrick W. Smith 于 12 月 8 日星期一出售了 10,000 股 Axon Enterprise 股票。股票以平均价格 551.92 美元出售，总价值为 5,519,200.00 美元。出售完成后，首席执行官持有 3,110,997 股公司股票，价值约为 1,717,021,464.24 美元。该交易使其持股减少了 0.32%。该交易已在向证券交易委员会提交的文件中披露，您可以通过此链接访问。此外，首席财务官 Brittany Bagley 于 12 月 11 日星期四出售了 2,000 股公司股票。该股票以平均价格 580.00 美元出售，总交易额为 1,160,000.00 美元。出售完成后，首席财务官持有 103,501 股公司股票，价值 60,030,580 美元。这代表其持股减少了 1.90%。该出售的披露信息可在 SEC 文件中找到。在过去三个月中，内部人士出售了 60,540 股公司股票，价值 35,632,038 美元。内部人士持有公司股票的 5.70%。</p>
<h2>Axon Enterprise 价格表现</h2>
<ul>
<li>AXON：竞争加剧，摩托罗拉以 44 亿美元收购</li>
</ul>
<p>AXON 在星期三的开盘价为 572.11 美元。该股票的市值为 451.5 亿美元，市盈率为 181.05，PEG 比率为 133.34，贝塔值为 1.40。Axon Enterprise, Inc 的一年最低价为 469.24 美元，一年最高价为 885.91 美元。该公司的流动比率为 3.12，速动比率为 2.89，债务股本比率为 0.57。该股票的 50 日移动平均价格为 594.96 美元，200 日移动平均价格为 697.64 美元。</p>
<p>Axon Enterprise (NASDAQ:AXON - 获取免费报告) 最近在 11 月 5 日发布了其财报。该生物技术公司报告本季度每股收益为 1.17 美元，低于市场共识预期的 1.63 美元，差额为 0.46 美元。该公司本季度的收入为 7.1064 亿美元，而分析师预期为 7.0483 亿美元。Axon Enterprise 的股本回报率为 4.29%，净利润率为 10.05%。该公司的季度收入同比增长 30.6%。在去年同期，该公司每股收益为 1.45 美元。分析师预测 Axon Enterprise, Inc 本财年将发布 5.8 美元的每股收益。</p>
<h2>Axon Enterprise 简介</h2>
<p>(免费报告)</p>
<p>Axon Enterprise, Inc 开发用于公共安全和执法机构的技术和武器系统，结合了硬件、软件和云服务。该公司的硬件产品组合包括电能武器（通常称为 TASER 设备）、佩戴式摄像头和车载摄像系统。Axon 将这些设备与一套连接产品和配件相结合，旨在捕捉、存储和管理现场证据。</p>
<p>除了硬件，Axon 还运营一个基于订阅的软件平台，用于数字证据管理、证据审查和记录管理。</p>
<h2>进一步阅读</h2>
<ul>
<li>五只我们更看好的股票，胜过 Axon Enterprise</li>
<li>请勿删除，立即阅读</li>
<li>崩盘已经开始（大多数人只是还没有看到）</li>
<li>警报：在 2026 年 1 月之前抛售这五只股票！</li>
<li>[无脑黄金投资]：“给我一个更好的投资。”</li>
<li>投资者警报：微型 “3 美元 AI 奇迹股票” 即将腾飞</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QVhPTg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QVhPTg"/></p>
<p><em>此即时新闻警报由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将有关此故事的任何问题或评论发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 Axon Enterprise 吗？</h2>
<p>在你考虑 Axon Enterprise 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 Axon Enterprise 并不在名单上。</p>
<p>虽然 Axon Enterprise 目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

AXON

<p>Shilanski & Associates Inc. 在第三季度减少了对 Axon Enterprise, Inc. (NASDAQ:AXON) 的持股比例，下降了 39.9%，目前持有 4,121 股，价值 296 万美元。其他对冲基金也调整了他们的持仓。分析师对 AXON 的评级不一，平均目标价为 802.71 美元。最近的内部交易包括首席执行官 Patrick W. Smith 出售了 10,000 股，首席财务官 Brittany Bagley 出售了 2,000 股。该股票开盘价为 572.11 美元，市值为 451.5 亿美元，市盈率为 181.05</p>

<p>Shilanski &amp; Associates Inc. trimmed its stake in Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 39.9% during the third quarter, according to its most recent filing with the Securities &amp; Exchange Commission. The fund owned 4,121 shares of the biotechnology company's stock after selling 2,737 shares during the quarter. Shilanski &amp; Associates Inc.'s holdings in Axon Enterprise were worth $2,957,000 at the end of the most recent quarter.</p>
<div class="lb-trans"><p>Shilanski &amp; Associates Inc. 在最近向证券交易委员会提交的文件中表示，在第三季度将其在 Axon Enterprise, Inc (NASDAQ:AXON - 免费报告) 的持股减少了 39.9%。该基金在季度内出售了 2,737 股后，持有生物技术公司 4,121 股股票。Shilanski &amp; Associates Inc. 在 Axon Enterprise 的持股在最近一个季度末价值为 2,957,000 美元。</p>
</div><p>Get <strong>Axon Enterprise</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>Axon Enterprise</strong> 的提醒：</p>
</div><ul>
<li>Why Axon's 16% Surge Signals a New Era in Public Safety Tech</li>
</ul>
<div class="lb-trans"><ul>
<li>为什么 Axon 的 16% 激增预示着公共安全技术的新纪元</li>
</ul>
</div><p>Several other hedge funds have also modified their holdings of the stock. Westside Investment Management Inc. increased its stake in Axon Enterprise by 4.8% in the 2nd quarter. Westside Investment Management Inc. now owns 283 shares of the biotechnology company's stock worth $225,000 after purchasing an additional 13 shares in the last quarter. CVA Family Office LLC lifted its stake in Axon Enterprise by 26.9% during the second quarter. CVA Family Office LLC now owns 66 shares of the biotechnology company's stock valued at $55,000 after buying an additional 14 shares in the last quarter. Newbridge Financial Services Group Inc. boosted its holdings in shares of Axon Enterprise by 2.8% in the second quarter. Newbridge Financial Services Group Inc. now owns 508 shares of the biotechnology company's stock worth $421,000 after buying an additional 14 shares during the period. Evergreen Capital Management LLC increased its position in shares of Axon Enterprise by 3.8% in the second quarter. Evergreen Capital Management LLC now owns 413 shares of the biotechnology company's stock worth $342,000 after acquiring an additional 15 shares in the last quarter. Finally, STF Management LP increased its position in shares of Axon Enterprise by 1.4% in the second quarter. STF Management LP now owns 1,164 shares of the biotechnology company's stock worth $964,000 after acquiring an additional 16 shares in the last quarter. 79.08% of the stock is owned by hedge funds and other institutional investors.</p>
<div class="lb-trans"><p>其他几家对冲基金也调整了对该股票的持股。Westside Investment Management Inc. 在第二季度将其在 Axon Enterprise 的持股增加了 4.8%。Westside Investment Management Inc. 目前持有 283 股生物技术公司的股票，价值 225,000 美元，此前在上个季度购买了额外的 13 股。CVA Family Office LLC 在第二季度将其在 Axon Enterprise 的持股增加了 26.9%。CVA Family Office LLC 目前持有 66 股生物技术公司的股票，价值 55,000 美元，此前在上个季度购买了额外的 14 股。Newbridge Financial Services Group Inc. 在第二季度将其在 Axon Enterprise 的持股增加了 2.8%。Newbridge Financial Services Group Inc. 目前持有 508 股生物技术公司的股票，价值 421,000 美元，此前在该期间购买了额外的 14 股。Evergreen Capital Management LLC 在第二季度将其在 Axon Enterprise 的持股增加了 3.8%。Evergreen Capital Management LLC 目前持有 413 股生物技术公司的股票，价值 342,000 美元，此前在上个季度购买了额外的 15 股。最后，STF Management LP 在第二季度将其在 Axon Enterprise 的持股增加了 1.4%。STF Management LP 目前持有 1,164 股生物技术公司的股票，价值 964,000 美元，此前在上个季度购买了额外的 16 股。79.08% 的股票由对冲基金和其他机构投资者持有。</p>
</div><h2>Wall Street Analysts Forecast Growth</h2>
<div class="lb-trans"><h2>华尔街分析师预测增长</h2>
</div><p>A number of research firms recently commented on AXON. Piper Sandler decreased their price objective on shares of Axon Enterprise from $893.00 to $753.00 and set an &#34;overweight&#34; rating for the company in a research note on Wednesday, November 5th. Needham &amp; Company LLC reaffirmed a &#34;buy&#34; rating and issued a $870.00 target price on shares of Axon Enterprise in a research report on Wednesday, September 24th. The Goldman Sachs Group lowered their price target on Axon Enterprise from $940.00 to $800.00 and set a &#34;buy&#34; rating on the stock in a report on Wednesday, November 5th. Royal Bank Of Canada began coverage on Axon Enterprise in a research note on Monday, November 17th. They issued an &#34;outperform&#34; rating and a $860.00 price objective for the company. Finally, Cowen restated a &#34;buy&#34; rating on shares of Axon Enterprise in a research report on Wednesday, November 5th. Fourteen research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company's stock. Based on data from MarketBeat, the stock has an average rating of &#34;Moderate Buy&#34; and an average price target of $802.71.</p>
<div class="lb-trans"><p>多家研究公司最近对 AXON 发表了评论。Piper Sandler 在 11 月 5 日的研究报告中将 Axon Enterprise 的目标价格从 893.00 美元下调至 753.00 美元，并对该公司给予了 “增持” 评级。Needham &amp; Company LLC 在 9 月 24 日的研究报告中重申了对 Axon Enterprise 的 “买入” 评级，并给出了 870.00 美元的目标价格。高盛集团在 11 月 5 日的报告中将 Axon Enterprise 的目标价格从 940.00 美元下调至 800.00 美元，并对该股票给予了 “买入” 评级。加拿大皇家银行在 11 月 17 日的研究报告中开始覆盖 Axon Enterprise，并给予了 “跑赢大盘” 评级和 860.00 美元的目标价格。最后，Cowen 在 11 月 5 日的研究报告中重申了对 Axon Enterprise 的 “买入” 评级。十四位研究分析师对该股票给予了买入评级，四位给予了持有评级。根据 MarketBeat 的数据，该股票的平均评级为 “适度买入”，平均目标价格为 802.71 美元。</p>
</div><ul>
<li>MarketBeat Week in Review – 06/02 - 06/06</li>
</ul>
<div class="lb-trans"><ul>
<li>MarketBeat 周回顾 – 06/02 - 06/06</li>
</ul>
</div><p><strong>Read Our Latest Research Report on AXON</strong></p>
<div class="lb-trans"><p><strong>阅读我们关于 AXON 的最新研究报告</strong></p>
</div><h2>Insider Transactions at Axon Enterprise</h2>
<div class="lb-trans"><h2>Axon Enterprise 的内部交易</h2>
</div><p>In related news, CEO Patrick W. Smith sold 10,000 shares of Axon Enterprise stock in a transaction on Monday, December 8th. The shares were sold at an average price of $551.92, for a total value of $5,519,200.00. Following the completion of the sale, the chief executive officer owned 3,110,997 shares of the company's stock, valued at approximately $1,717,021,464.24. The trade was a 0.32% decrease in their position. The transaction was disclosed in a document filed with the Securities &amp; Exchange Commission, which is accessible through this link. Also, CFO Brittany Bagley sold 2,000 shares of the company's stock in a transaction on Thursday, December 11th. The stock was sold at an average price of $580.00, for a total transaction of $1,160,000.00. Following the completion of the sale, the chief financial officer owned 103,501 shares of the company's stock, valued at $60,030,580. This represents a 1.90% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders sold 60,540 shares of company stock valued at $35,632,038. Insiders own 5.70% of the company's stock.</p>
<div class="lb-trans"><p>在相关消息中，首席执行官 Patrick W. Smith 于 12 月 8 日星期一出售了 10,000 股 Axon Enterprise 股票。股票以平均价格 551.92 美元出售，总价值为 5,519,200.00 美元。出售完成后，首席执行官持有 3,110,997 股公司股票，价值约为 1,717,021,464.24 美元。该交易使其持股减少了 0.32%。该交易已在向证券交易委员会提交的文件中披露，您可以通过此链接访问。此外，首席财务官 Brittany Bagley 于 12 月 11 日星期四出售了 2,000 股公司股票。该股票以平均价格 580.00 美元出售，总交易额为 1,160,000.00 美元。出售完成后，首席财务官持有 103,501 股公司股票，价值 60,030,580 美元。这代表其持股减少了 1.90%。该出售的披露信息可在 SEC 文件中找到。在过去三个月中，内部人士出售了 60,540 股公司股票，价值 35,632,038 美元。内部人士持有公司股票的 5.70%。</p>
</div><h2>Axon Enterprise Price Performance</h2>
<div class="lb-trans"><h2>Axon Enterprise 价格表现</h2>
</div><ul>
<li>AXON: Competition Intensifies as Motorola Makes $4.4B Acquisition</li>
</ul>
<div class="lb-trans"><ul>
<li>AXON：竞争加剧，摩托罗拉以 44 亿美元收购</li>
</ul>
</div><p>AXON opened at $572.11 on Wednesday. The stock has a market cap of $45.15 billion, a price-to-earnings ratio of 181.05, a PEG ratio of 133.34 and a beta of 1.40. Axon Enterprise, Inc has a 1 year low of $469.24 and a 1 year high of $885.91. The company has a current ratio of 3.12, a quick ratio of 2.89 and a debt-to-equity ratio of 0.57. The stock has a fifty day moving average price of $594.96 and a 200 day moving average price of $697.64.</p>
<div class="lb-trans"><p>AXON 在星期三的开盘价为 572.11 美元。该股票的市值为 451.5 亿美元，市盈率为 181.05，PEG 比率为 133.34，贝塔值为 1.40。Axon Enterprise, Inc 的一年最低价为 469.24 美元，一年最高价为 885.91 美元。该公司的流动比率为 3.12，速动比率为 2.89，债务股本比率为 0.57。该股票的 50 日移动平均价格为 594.96 美元，200 日移动平均价格为 697.64 美元。</p>
</div><p>Axon Enterprise (NASDAQ:AXON - Get Free Report) last issued its earnings results on Wednesday, November 5th. The biotechnology company reported $1.17 earnings per share for the quarter, missing the consensus estimate of $1.63 by ($0.46). The firm had revenue of $710.64 million during the quarter, compared to analyst estimates of $704.83 million. Axon Enterprise had a return on equity of 4.29% and a net margin of 10.05%.The business's revenue for the quarter was up 30.6% on a year-over-year basis. During the same period in the previous year, the company earned $1.45 earnings per share. Analysts forecast that Axon Enterprise, Inc will post 5.8 EPS for the current fiscal year.</p>
<div class="lb-trans"><p>Axon Enterprise (NASDAQ:AXON - 获取免费报告) 最近在 11 月 5 日发布了其财报。该生物技术公司报告本季度每股收益为 1.17 美元，低于市场共识预期的 1.63 美元，差额为 0.46 美元。该公司本季度的收入为 7.1064 亿美元，而分析师预期为 7.0483 亿美元。Axon Enterprise 的股本回报率为 4.29%，净利润率为 10.05%。该公司的季度收入同比增长 30.6%。在去年同期，该公司每股收益为 1.45 美元。分析师预测 Axon Enterprise, Inc 本财年将发布 5.8 美元的每股收益。</p>
</div><h2>Axon Enterprise Profile</h2>
<div class="lb-trans"><h2>Axon Enterprise 简介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>(免费报告)</p>
</div><p>Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company's hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.</p>
<div class="lb-trans"><p>Axon Enterprise, Inc 开发用于公共安全和执法机构的技术和武器系统，结合了硬件、软件和云服务。该公司的硬件产品组合包括电能武器（通常称为 TASER 设备）、佩戴式摄像头和车载摄像系统。Axon 将这些设备与一套连接产品和配件相结合，旨在捕捉、存储和管理现场证据。</p>
</div><p>Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.</p>
<div class="lb-trans"><p>除了硬件，Axon 还运营一个基于订阅的软件平台，用于数字证据管理、证据审查和记录管理。</p>
</div><h2>Further Reading</h2>
<div class="lb-trans"><h2>进一步阅读</h2>
</div><ul>
<li>Five stocks we like better than Axon Enterprise</li>
<li>Do not delete, read immediately</li>
<li>The Crash Has Already Started (Most Just Don’t See It Yet)</li>
<li>ALERT: Drop these 5 stocks before January 2026!</li>
<li>[No Brainer Gold Play]: “Show me a better investment.”</li>
<li>INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票，胜过 Axon Enterprise</li>
<li>请勿删除，立即阅读</li>
<li>崩盘已经开始（大多数人只是还没有看到）</li>
<li>警报：在 2026 年 1 月之前抛售这五只股票！</li>
<li>[无脑黄金投资]：“给我一个更好的投资。”</li>
<li>投资者警报：微型 “3 美元 AI 奇迹股票” 即将腾飞</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QVhPTg" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NASDAQ&amp;Symbol=AXON"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻警报由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将有关此故事的任何问题或评论发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Axon Enterprise Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Axon Enterprise 吗？</h2>
</div><p>Before you consider Axon Enterprise, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考虑 Axon Enterprise 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Axon Enterprise wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 Axon Enterprise 并不在名单上。</p>
</div><p>While Axon Enterprise currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Axon Enterprise 目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Shilanski & Associates Inc. 减少了其在 Axon Enterprise, Inc $AXON 的股票头寸